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ABSTRACT The streptavidin scaffold was expanded with well-structured naturally occurring 
motifs. These chimeric scaffolds were tested as host for biotinylated catalysts as artificial 
metalloenzymes (ArM) for asymmetric transfer hydrogenation, ring closing metathesis and anion 
π catalysis. The additional second coordination sphere elements were shown to significantly 
influence both the activity and the selectivity of the resulting hybrid catalysts. These findings 
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have identified propitious chimeric streptavidins for future directed evolution efforts of artificial 
metalloenzymes. 
INTRODUCTION: Artificial metalloenzymes (ArMs hereafter), as introduced by Whitesides in 
1978,1 aim to combine the best features of both enzymes and homogeneous catalysts. ArMs aren 
made by anchoring an abiotic cofactor within a host protein.2-7 This field has gained popularity 
thanks to the widespread use of molecular biology and recombinant protein production. Since 
our first report on ArMs based on the biotin-streptavidin technology in 2003,8 we have 
systematically pursued a chemo-genetic optimization strategy to improve the performance of 
these hybrid catalysts incrementally.9-10 Critically, this versatile strategy relies on our ability of 
produce streptavidin (Sav) libraries and to screen these with a variety of different biotinylated 
cofactors. Having identified an active ArM, twenty to fifty single, double and triple point Sav 
mutants are typically screened using standard directed evolution schemes. Despite the versatility 
of site-directed mutagenesis and directed evolution,11 point mutations do not allow the major 
remodeling of the active site. While such optimization efforts have proven successful, resulting 
in up to hundred fold increase in rate,12 more-diverse libraries may allow further optimization of 
ArMs displaying catalytic efficiencies approaching those of natural enzymes.13-15 The structures 
of ArMs based on the biotin-streptavidin technology highlights the narrow dispersion of the 
position of metal within the biotin-binding vestibule. With few exceptions however, each ArM 
requires a different Sav mutant for improved performance.16  
Inspection of the biotin-binding vestibule of Sav where the catalytic event occurs suggests that 
it is ideally suited to host both the cofactor and its substrate. However, the low plasticity of Sav, 
as revealed by superposition of X-ray structures of Sav and metal-loaded Sav, as well as its 
shallow “active site” exposes the metal to the reaction medium (Figure 1). We hypothesized that 
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the introduction of additional structural features may offer opportunities to protect the active site. 
With this goal in mind, we set out to engineer Sav by introducing additional structural motifs 
around the biotin-binding vestibule. The chimeras presented herein were designed to enable the 
exploration of diverse topologies around the active site by the introduction of additional second 
coordination-sphere elements.17 
Figure 1. Close-up view of the X-ray structure of homotetrameric Sav S112A with one 
biotinylated cofactor [Cp*Ir(biot-p-L)Cl] bound (PDB ID 3PK2).18 The surface representation 
displays a single cofactor (stick representation; Ir, orange sphere, Cl, green) and close-lying 
amino-acid residues (color code: red = acidic, blue = basic, green = polar, white = apolar). The 
shallowness of the biotin-binding vestibule (i.e., the active site) suggests that engineering 
additional structural motifs may provide additional second coordination sphere elements around 
the biotinylated cofactor.  
Thus, we set out to modify the ArMs genetically to introduce well-defined secondary 
structures around the active site. Thanks to the dimer-of-dimer nature of homotetrameric Sav, 
genetic modifications are reflected twice in each of the two active sites (Figure 2) and thus can 
be anticipated to have a significant shielding effect on the Sav-embedded cofactor.  
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Figure 2. Cartoon representation of a homotetrameric Sav (surface representation) construct 
bearing an additional motif (entry 8 in Table 1) engineered in loop 3,4 (yellow cartoon 
representation). This model for the chimeric protein was generated from PDB ID 3PK2 using 
homology modeling and structure refinement with Yasara. (color code: red = acidic, blue = 
basic, green = polar, white = apolar) 
RESULTS AND DISCUSSION 
Protein design. Our initial efforts focused on inserting (GGX)n repeat sequences (where X = 
…., and n = 1 – 8) at various loop positions that make up the biotin-binding vestibule. We 
selected the following positions for these insertions: G48–N49, T66–D67, R84–N85 and A117–
N118 to introduce one or two (GGX)n repeat motifs (Table 1). 
Table 1 Summary of the expressed Sav constructs bearing (GGX)n repeat sequences. 
entry Sav loop loop sequence N° of 
(GGX)n
repeats
Expression 
levela (mg/l)1 3/4 G48-GGSGGS-N49 2 13.8  
2 4/5 T66-GGSGGS-D67 2 16.3 
3 5/6 R84-GGSGGS-N85 2 13.0 
4 7/8 A117-GGSGGS-N118 2 not purified 
5 3/4 + 4/5 G48-GGSGGS-N49 
T66-GGSGGS-D67
4 1.5 
6 3/4 + 5/6 G48-GGSGGS-N49 
R84-GGSGGS-N85
4 0.9 
7 3/4 + 7/8 G48-GGSGGS-N49 
A117-GGSGGS-N118
4 not purified 
8 3/4 G48-GGNGGNGGGGGVGGS-N49 5 55.0 
9 3/4 G48-GGIGGSGGGGGHGGRGGGGGVGGS-N49 8 not purified 
10 3/4 G48-GGNGGSGGGGGGGGSGGSGGS-N49 7 not purified 
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11 3/4 G48-GGRGGGGGHGGCGGVGGS-N49 6 not purified 
aExpressed as soluble and functional (i.e. binds biotin-4-fluorescein) tetrameric fraction. The 
expression conditions are detailed in the SI.  
Having identified Sav positions tolerant to (GGX)n insertions, we set out to replace these GGX 
repeats, which we presumed would be unstructured, by naturally occurring motifs with a well-
defined secondary structure. We pursued the construction of two different chimera streptavidin 
families: a) streptavidin containing an extended 2D topology structure (24 – 60 amino acid 
residues, 2D_Sav, hereafter, Table 2) and b) streptavidin containing shorter naturally occurring 
loops (5-12 amino acid residues, MP_Sav, hereafter, Table 3). 
The first family with additional structured elements around the biotin-binding vestibule, 
2D_Sav, was created by fusion with highly conserved and structured peptide sequences (see SI) 
that display close-lying N and C termini. For this purpose, the following sequences were 
selected: SH3 (Src Homology 3 domain, 60 aa) containing antiparallel β-sheets,19 AR (Ankyrin, 
30-34 aa),20 HP (Villin Headpiece subdomain, 35 aa),21 FPD (FoldIt Players Design, 24 aa)22 
containing an helix-turn-helix motif, and PPR (Penta-trico-Peptide Repeat, 35 aa) containing a 
coiled-coil domain23 (Figure 3 and Table 2). Inspection of the X-ray structure of mature apo-Sav, 
which bears an Nterm-T7-solubility tag at positions 1 – 12 and extends to position 159,24 revealed 
that the Cterm  occupies the biotin-binding site.
25 Therefore, we introduced at the Cterm either the 
SH3 or PPR consensus sequence to provide an additional well-structured secondary structure 
close to biotin-binding vestibule. The SH3, AR, HP and FDP motifs were introduced in four 
different loop regions of Sav taking into consideration their Nterm – Cterm distance. Thus, nineteen 
different chimeric Sav genes were constructed (Figure 3 and Table 2). 
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Figure 3 Surface display representation of the Sav tetramer. Monomer surfaces are highlighted 
in green, yellow, red and translucent grey. The Sav loops that were engineered to create chimera 
proteins are labelled: loop 3/4, residues 46 – 52; loop 4/5, residues 63 – 70; loop 5/6, residues 82 
– 87; and loop 7/8, residues 113 – 117). The inserted structures with Nterm-Cterm distances 
(N·····C) are displayed as grey cartoon representation: SH3 (Src Homology 3 domain, ca. 60 
aa, antiparallel β-sheets);19 AR (Ankyrin, 30-34 aa, helix-turn-helix);20 HP (Villin Headpiece 
subdomain, 35 aa, helix-turn-helix);21 FPD (FoldIt Players Design, 24 aa, helix-turn-helix);22 and 
PPR (Penta-trico-Peptide Repeat 35 aa, coiled coil).23 The yellow the star highlights the position 
selected for the creation of Chimera MP_Sav family. 
Table 2. Chimeric Proteins (2D_Sav’s family) produced recombinantly in this study. Each 
protein is abbreviated with the acronym of the introduced motif; the number indicates the 
position of the insertion in the original Sav sequence.a 
entry abbreviation MW (g/mol)b solubility 
1 PPR_159 20515.5 Yes 
2 SH3_46-52 22877.2 After refolding 
3 SH3_63-70 22819.2 No 
4 SH3_82-87 22843.1 No 
5 SH3_113-117 23016.4 After refolding 
6 SH3_159 23347.7 Yes 
7 AR_46-52 19457.4 After refolding 
8 AR_64-70 19496.5 After refolding 
9 AR_81-84 19650.5 No 
10 AR_115-117 19798.8 After refolding 
11 HP_46-52 20018.0 Yes 
12 HP_63-70 19960.0 After refolding 
13 HP_64-70 20057.2 Yes 
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14 HP_82-84 20325.4 Yes 
15 HP_113-117 20157.3 No 
16 FDP_46_52 18313.0 Yes 
17 FDP_64-70 18352.1 After refolding 
18 FDP_81-84 18506.2 Yes 
19 FDP_115-117 18654.4 After refolding 
a The expression and refolding conditions are detailed in the SI. b Molecular weight of the 
monomer.  
The second family of chimera, MP_Sav, was generated by selecting natural loops with 
appropriate Nterm–Cterm distances for the substitution of Sav’s residues between A46 and A50 
(loop 3/4, Figure 3). To generate initial models of the chimeric proteins, a database of loop 
regions from X-ray protein crystal structures from the Protein Data Bank[REF] was created 
using ISAMBARD.26 Loops were defined as any continuous region of backbone containing any 
mixture of random coil, hydrogen-bonded turn isolated beta-bridge or bend, as identified by 
DSSP.27-28 Tools within ISAMBARD were then used to extract the backbone structure of the 
loop, which was stored in a database along with the PDB ID, chain and residue labels, 
surrounding regions of secondary structure, sequence, end-to-end distance (i.e. the distance 
between the C of the residue preceding the loop and the C of the residue immediately after the 
loop) and resolution of the X-ray structure. Redundant sequences were not removed from the 
database to allow any conformational diversity of the loops to be captured, with the rationale that 
different structures of the same, or homologous proteins, might contain very different loop 
conformations due to their highly flexible nature. Candidate loop designs were identified to span 
residue A46 and A50 of Sav (loop 3/4) based on an X-ray protein crystal structure (PDB ID 
3PK2). Initially, these were filtered purely based on the end-to-end distance of the loop, 
requiring it to be within 0.5 Å of the A46 – A50 distance in 3PK2. Loops satisfying this criterion 
were fitted by aligning the backbone atoms of the first and the last residues of the loop with those 
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of residues A46 and A50, respectively. The root-mean square deviation (RMSD) of the distances 
between complementary backbone atom pairs was calculated to evaluate the quality of the fit 
(detailed in the SI). Models were sorted based on this quality and the candidate loops were 
evaluated manually considering the diversity of number and nature of amino acids, symmetry 
and proximity to the metal center. On this basis, twelve loops were selected for insertion into Sav 
between A46 and A50 (Table 3 and Figure 4). Subsequently, the family members of MP_Sav’s 
were subjected to a first round of mutagenesis in which cationic arginine and/or lysine residues 
in the loop sequences, which are known to be detrimental to catalysis,29 were mutated to either 
alanine or phenylalanine. Finally, a K121F mutation was made in the first and second generation 
of MP3 constructs because of its improved catalytic performance with various ArMs based on 
the biotin-streptavidin technology.30 
Table 3. Selected chimera of MP_Sav family containing natural loops with commensurate Nterm–
Cterm topologies inserted between A46 and A50 of Sav. ISAMBARD was used to create a 
database of loops regions from known X-ray crystal structures.a  
entry abbreviation inserted sequencea abbreviation second generation MP_Sava 
1 WT AVGNAb   
2 MP 1 GKTKG MP 1 K-F GATFG 
3 MP 2 GRSRG  – 
4 MP 3 GNLKYGc MP 3 K-A GNLAYGc 
GNLFYG 
5 MP 4 GIDRNG  – 
6 MP 5 GDMKPRG  – 
7 MP 6 GHEKRDG MP 6 K-A_R-F GHEAFDG 
8 MP 7 GKHNKPDDCG  – 
9 MP 8 GRRQIGTRSG  – 
10 MP 9 GEPFGGEKING MP 9 K-F GEPFGGEFING 
11 MP 10 GGRVIPVKLGG  – 
12 MP 11 GYLSSQNGQPG  – 
13 MP 12 GTERPSKNSHPG MP 12 R-A_K-F GTEAPSFNSHPG 
a The expression and refolding conditions are detailed in the SI. b Sequence deleted from the 
WT in the MP constructs. c Third generation of MP_Sav was generated combining this loop 
sequence and K121F 
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Figure 4. a) Model of MP_Sav member (MP_11) containing the loop GYLSSQNGQPG 
insertion (dark grey) between Sav position A46 and A50 generated from PDB file 3PK2. The 
insertion partially shields the biotin-binding vestibule. b) For comparison the surface 
representation of PDB ID 3PK2 is displayed in the same orientation. Color code: red, acidic 
residues; blue, basic; green, polar; and white, apolar. 
Protein overexpression. BL21(DE3) E. coli cells and pET24 (+) plasmids was used for the 
overexpression of all chimeric streptavidins using an autoinduction medium.31 After cell lysis, 
SDS gel analysis of the supernatant confirmed overexpression and the biotin-binding capacity of 
the proteins. For this purpose, biotin-4-fluorescein (B4F) was added to the Sav chimeras, and the 
presence of fluorescent bands in SDS PAGE confirmed correct folding and function of the Sav 
constructs. While the majority of the constructs with the shorter loops gave soluble and correctly 
folded proteins, the 2D_Sav family members had different folding behaviors depending on: i) the 
type of motif used; and ii) the site of insertion. Proteins containing PPR and SH3 at the C 
terminus were usually well folded, as were the Sav chimeras with either HP and FDP motifs 
engineered in either loop 3/4 or 5/6. As summarized in Table 2, some Sav constructs were 
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produced as inclusion bodies, however. Gratifyingly, these insoluble aggregates bound B4F, 
highlighting their biotin-binding activity. Screening various refolding buffers revealed that all 
insoluble chimeras could be refolded using a highly dilute MES buffer (see SI). Following this 
step when required, all constructs presented herein could be purified using a biotin-sepharose 
affinity column (Tables 2 and 3 and Figure 3). After purification, all the constructs were 
characterized by SDS PAGE and mass-spectroscopy (See SI). 
Catalytic performance. Next, chimeric Sav were combined with various biotinylated 
cofactors and tested as artificial metalloenzymes in the following catalytic reactions: asymmetric 
transfer hydrogenation (ATH), ring-closing metathesis (RCM), and anion π-catalysis (ANPI). 
The respective biotinylated catalysts used are displayed in Figure 5. 
 
Figure 5. Biotinylated cofactors used to complete the holoenzymes for: i) asymmetric transfer 
hydrogenation reaction using [Cp*Ir(biot-L)Cl] 1; ii) ring-closing metathesis using a Hoveyda–
Grubbs second-generation catalyst (biot-Ru 2 hereafter); and iii) anion π catalysis using 
naphthalenediimide (biot-NDI 3 hereafter).  
Previous work shows that the Ir-d6 piano-stool [Cp*Ir(biot-L)Cl] 1 is the most active ATH 
catalysts for the reduction of prochiral imines in the presence of Sav.32-33 Two different prochiral 
cyclic imines 4 and 6 were selected and the results of the asymmetric transfer hydrogenation, 
using [Cp*Ir(biot-L)Cl] 1, are collected in Table 4. Compared to the free cofactor [Cp*Ir(biot-
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L)Cl] 1 (Table 4 entries 1 and 2) and the corresponding benchmark ATHase [Cp*Ir(biot-L)Cl] · 
WT Sav (Table 4 entries 3 and 4), some of the engineered Sav constructs performed better, both 
in terms of TON (turnover number) and enantioselectivity. While the improvement of 
enantioselectivity was modest, the TON number improved two-fold for substrate 4 (Table 4 
entries 5 and 6) and seven-fold for substrate 6 (Table 4 entries 7 and 8). Strikingly, the position 
of the insertions plays a critical role in the activity of the corresponding ATHase. Insertion in 
loop 3/4 (i.e., positions 46 – 52) affords the most active ATHases, for both HP_46-52 and 
FDP_46-52 constructs, Table 4. For comparison, introduction of the HP in the loop 4/5 (i.e., 
positions 64 – 70) had a negative impact on the ATHase activity (Table 4 entry 9). We 
hypothesize that the insertion between positions 46 – 52 projects the loop in the proximity of the 
Ir-center and thus has the highest (positive) impact on the ATHase's performance. While the 
improvement in selectivity remains modest, the activity is significantly affected, resulting in up 
to a sevenfold increase in turnovers after sixteen hours. 
 
Table 4. Selected ATHase results obtained with the 2D_Sav combined with [Cp*Ir(biot-L)Cl] 1a 
 
entry 2D_Sav substrate e.e(R) TON catalytic 
improvement vs 
WT Savb 
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1 No protein 4 0 197 - 
2 No protein 6 0 0 - 
3 WT Sav 4 45 170 - 
4 WT Sav 6 76 22 - 
5 HP_46-52 4 59 223 1.3 
6 FDP_46-52 4 51 340 2 
7 HP_46-52 6 80 162 7.3 
8 FDP_46-52 6 82 158 7.2 
9 HP_64-70 4 22 14 0.1 
a reaction conditions: substrates 10 mM, 16 h, 37 °C, [Cp*Ir(biot-L)Cl] 1 10 µM, Sav’s FBS 20 
µM, MOPS 0,6 M, pH = 7,5, formate 3 M, Vtot = 200 µL.
b Ratio between TON 2D_Sav and 
TON of WT Sav. 
 
Considering the MP_Sav constructs, a general trend is observed in the reduction of substrate 4: 
Whilst the first-round Lys/Arg-containing loop sequences had dramatically lower activities than 
and comparable selectivities to the benchmark ATHase [Cp*Ir(biot-L)Cl] 1 · WT Sav (Table 5 
entries 3 vs entries 6 – 10), point mutations of Lys to Ala or Phe resulted in second-generation 
hybrid catalysts that rivaled or outperformed the WT ATHase (Table 5, entries 11 – 12). The 
[Cp*Ir(biot-L)Cl] 1 · Sav K121F ATHase displayed significantly improved TON although this 
was at the cost of ee (13% ee (S)-5, 970 TON and 45% ee (R)-5, 170 TON  for Sav K121F and 
WT, respectively). Combining the beneficial K121F mutation and loops, with or without Lys 
residue, in all cases gives ATHase with lower TONs compared to Sav K121F (Table 5, entries 13 
– 14). For substrate 6, all second-generation MP_Sav performed better than the corresponding 
ATHase [Cp*Ir(biot-L)Cl] 1 · WT Sav (Table 5 entry 4 vs Table 5 entries 15 – 17). However 
[Cp*Ir(biot-L)Cl] 1 · Sav K121F followed by the chimera [Cp*Ir(biot-L)Cl] 1 · Sav HP_46-52 
and [Cp*Ir(biot-L)Cl] 1 · Sav FDP_46-52 were the most active ATHases (Table 5 entry 5 and 
Table 4 entries 7 and 8). A summary of all ATHase experiments is presented in SI Tables S4 and 
S5. 
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Table 5. Selected ATHase results obtained for the MP_Sav introduced between position A46 
and A50 combined with [Cp*Ir(biot-L)Cl] 1.a 
entry MP_Savb,c substrate e.e(R) TON catalytic 
improvement 
vs WT Savd 
1 No protein 4 0 197 - 
2 No protein 6 0d 0 - 
3 WT Sav 4 45 170 - 
4 WT Sav 6 76 22 - 
5 Sav K121F 4 -13 (S) 970 5.7 
6 MP 3 4 53 6 0.04 
7 MP 4 4 42 67 0.4 
8 MP 9 4 53 82 0.48 
9 MP 11 4 45 61 0.36 
10 MP 12 4 62 15 0.08 
11 MP 3_K-A 4 46 192 1.13 
12 MP 9_K-F 4 49 198 1.16 
13 MP 3_K121F 4 15 568 3.35 
14 MP 3_K-A-K121F 4 14 462 2.7 
15 MP 3_K-A 6 79 57 2.5 
16 MP 6_K-A_R-F 6 77 100 4.55 
17 MP 9_K-F 6 80 71 3.2 
a reaction conditions: substrates 10 mM, 16 h, 37°C, [Cp*Ir(biot-L)Cl] 1 10 µM, Sav’s Free 
Binding Site (FBS) 20 µM, MOPS 0,6 M, pH = 7,5, formate 3 M, Vtot = 200 µL. 
b The 
numbering of the residues of Sav was kept identical to the WT numbering, eventhough the 
insertion may be placed before the position of the mutation. c Italicized one letter aminoacid 
abbreviations designate cationic aminoacids within the inserted loops that were mutated to either 
A or F to probe the effect of the charge on the catalytic performance (See Table 3 for details).d 
Ratio between TON MP_Sav and TON WT Sav. 
 
Building on our previous work on olefin metathesis in aqueous phase,34 we investigated the 
catalytic behavior of 2D_Sav and MP_Sav scaffolds in the presence of biot-Ru 2. The resulting 
artificial metathases were tested for the RCM of substrate 8. Both the biot-Ru 2 · Sav HP_64-70 
and biot-Ru 2 · Sav PPR_159 outperformed the bare catalyst (Table 6, entries 1 vs 4 and 5). As 
for the ATHases, introduction of a phenylalanine residue at position K121 improved catalytic 
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performance resulting in 105 TONs (Table 6, entry 3). The second- and the third-generation 
MP_Sav’s variants originating from the Sav_MP3 sequence displayed improved activity (Table 
6 entries 6-8). However, compared to biot-Ru 2 ·Sav K121F, none of the newly designed 
chimeric Sav outperformed this single point mutant (Table 6 entries 4-8). A complete list of 
chimeric metathases is collected in SI Table S6. 
 
Table 6. Selected results for RCM of diallyl substrate 8 using 2D_Sav and MP_Sav.a  
 
entry Sav b,c TON 
1 No protein 38 
2 WT Sav 87 
3 K121F 105 
4 HP_64-70 56 
5 PPR_159 64 
6 MP 3_K-A 61 
7 MP 3_K121F 88 
8 MP 3_K-A-K121F 98 
a reaction conditions: substrate 8 10 mM, biot-Ru 2 10 µM, 16 h, 37°C, Chim_Sav and 
MP_Sav 20 µM Free Binding Site, acetate buffer 100 mM, 0.5 M MgCl2 pH = 4.0, Vtot = 200 
µL. b The numbering of the residues of Sav were kept as the WT numbering, eventhough the 
insertion may be placed before the position of the mutation. c Italicized residues designate 
cationic aminoacids in the inserted loops that were mutated to either A or F to probe the effect of 
the charge on the catalytic performance (See Table 3 for details) 
 
 15 
The Michael addition of malonic acid half thioester 10 (MAHT) was investigated next. This 
reaction is of interest as it mimics the first step of the polyketide biosynthesis. Importantly, 
anion-π interactions were shown to have a significant impact on the chemoselectivty of this 
reaction by selectively producing the disfavored addition product 12 A. Without an electron-
deficient π-system as the catalyst, the decarboxylation product 13 D is generated almost 
exclusively.35-36 Naphthalenediimides (NDIs) are π-acidic surfaces with proven efficiencies as 
primary component in anion-π catalysts. By linking a biotin to an NDI π-surface and 
incorporation within Sav anion-π enzymes result. These artificial enzymes produce the addition 
product 12 A with an exquisite chemoselectivity (A/D ratio > 30) and enantioselectivity (ee = 
95% for biot-NDI 3· Sav S112Y)37 through synergism between NDIs and Sav mutants. 
However, due the inhibition by anions, the use of a more confined cavity may be of interest. 
With this goal in mind, the catalysis was tested with the previously established conditions.37  
Most of the chimeric Sav’s produced the addition product 12 A with excellent chemoselectivity 
(12 A/ 13 D > 30) and moderate yields (up to 61 Yield%, Table 7 entry 2). Three of the chimeric 
Sav’s were inactive. We posit that the lack of reaction may be attributed to an important 
shielding above the NDI surface embedded in either MP 12 Sav, Sav FDP_46-52 and Sav 
HP_46-52. Only biot-NDI 3 · Sav PPR_159, containing the coiled-coil domain at the Cterm 
afforded 12 A with an enantioselectivity (Table 7, entry 3), thus competing with the most 
efficient anion-π organocatalysts achieved to date.36, 38 A summary of all π experiments is 
presented in SI, Table S7. 
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Table 7. Selected results obtained for anion-π catalysis using biot-NDI 3 · 2D_Sav or  biot-
NDI 3 · MP_Sav.a 
 
entry Savb,c yield % 12 A/13 D ee (%) 
1 WT Sav 60 >30 41 
2 MP 12_R-A_K-F 61 >30 0 
3 PPR_159 57 >30 22 
4 MP 3_K-A_K121F 55 >30 0 
5 MP 3_K121F 51 >30 0 
6 MP 9 23 >30 0 
7 MP 9_K-F 45 >30 0 
8 MP 12 traces nd 0 
9 FDP_46-52 0 nd nd 
10 HP_46-52 0 nd nd 
aReaction conditions: biot NDI 3 10 mol%, Sav’s FBS 20 mol %, CD3CN/Glycine buffer pH = 
3, substrate 10 5 mM, substrate 11 50 mM. b The numbering of the residues of Sav were kept as 
that of WT Sav, eventhough the insertion may be placed before the position of the mutation. c 
Italicized residues designate cationic aminoacids in the inserted loops that were mutated to either 
A or F to probe the effect of the charge on the catalytic performance (See Table 3 for details). 
 
 
OUTLOOK 
The catalytic performance of ArMs derived from the chimeric Savs described herein suggest 
that these straightforward modifications to the host can have significant impacts on catalytic 
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activity. Thanks to the remarkable quaternary stability of the Sav scaffold, introduction of 
additional structural motifs lead, in the vast majority of cases, to soluble and functional chimeric 
Savs. For the ATHase, the resulting activity was up to sevenfold higher than the parent WT Sav. 
Thus, this strategy of embellishing loops proximal to the active site offers a versatile means to 
complement directed evolution efforts to optimize the performance of the ArMs based on the 
biotin-streptavidin technology. The newly introduced structural motifs might be further 
engineered to form a protective lid over the active site, resulting in ArMs able to perform 
catalytic reactions in cell free extracts or in the cytoplasm. 
 
EXPERIMENTAL SECTION 
General procedure for the asymmetric transfer hydrogenation. 10 µl of proteins stock 
solution in Milli-Q H2O (200 µM free binding site) was added to 185 µl of reaction buffer 
followed by the addition of 5 µl of the biotinylated metal complex [Cp*Ir(biot-L)Cl] 1 from a 
stock solution (0.4 mM in DMSO). The solution was mixed for 20 min at 37 °C and 800 rpm in a 
thermo-mixer for precomplexation. Finally, 5 µl of substrate 4 or 6 stock solution (400 mM in 
DMSO) was added and the mixture was stirred at 37 °C for 16 h. Subsequently, 20% NaOH  
solution was added to the reaction mixture, followed by the addition of CH2Cl2. After mixing, 
the organic phase was separated and dried with anhydrous Na2SO4. Solids were separated 
through centrifugation and the supernatant was analyzed by using HPLC or GC. 
General procedure for ring closing metathesis. In a 1.2 mL glass vial, 10 µl of protein stock 
solution (400 µM) and 5 µl biot Ru 2 (400 µM) were added to 85 µl of reaction buffer and 
incubated at 37°C for 20 min. After incubation, 100 µl of substrate 20 mM were added to the 
reaction mixture and the reaction was stirred at 37°C for 16 hours at 1000 rpm. After reaction, 
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methanol and the internal standard were added to the reaction mixture and the whole volume 
transferred to Eppendorf tubes for centrifugation. The supernatant was then transferred into 
HPLC vials containing MQ water and the sample analyzed by UPLC-MS for the quantification 
of product 9. 
General procedure for anion π catalysis. Stock solutions of substrates 10 (40 mM), 11 (400 
mM) and biot NDI 3 (2 mM) were prepared in CD3CN. Solutions of substrates 10 should be 
freshly prepared as decarboxylation to afford 13 D build-up on aging. Solutions were prepared 
by mixing successively streptavidin WT or mutants, biotinylated ligand 3, substrates 10, 11 and 
stirred at 20 °C. After 24h, the mixture was extracted with CDCl3 , dried over Na2SO4, and 
filtered and analyzed by 1H-NMR . 
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